Products for Research Use Only
RegisterLogin

RLY-2608

CAT: 1410-M37293-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:1410-M37293-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
RLY-2608 is a selective mutant PI3Kα inhibitor that inhibits tumor growth in a PIK3CA mutant xenograft model.
CAS Number
2733573-94-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
608.91
Molecular Formula
C29H14ClF5N6O2
Notes
Research use only, not for human use.
Receptor
PI3K

Related Products

CatalogName
M13282-01BETd-260
M13228-01TPT-260
M13421BETd-260 trifluoroacetate

Alternative Products

CatalogName
BA8734-1RLY-2608
GTR19269014-01(S) -RLY-2608
A24163-100Lirafugratinib (RLY-4008) 100mg
A24163-10Lirafugratinib (RLY-4008) 10mg
A24163-50Lirafugratinib (RLY-4008) 50mg
A24163-5Lirafugratinib (RLY-4008) 5mg
BNUM2608-50NRF1 (NRF1/2608), 1mg/mL
BNUB2608-500NRF1 (NRF1/2608), 0.2mg/mL
NBP3-07450-20ugMouse Monoclonal Nrf1 Antibody (NRF1/2608)
36-2872-20Anti-NRF1 Monoclonal Antibody (Clone: NRF1/2608)

Popular Products